Experimental cell research最新文献

{"title":"Histone H3 lysine 18 lactylation promotes alveolar epithelial cell apoptosis in sepsis-induced lung injury by upregulating caspase-8 in vivo and in vitro","authors":"Ping Lin ,&nbsp;Yu Wang ,&nbsp;Xiaoqian Li ,&nbsp;Zongan Liang ,&nbsp;Ting Wang","doi":"10.1016/j.yexcr.2025.114843","DOIUrl":"10.1016/j.yexcr.2025.114843","url":null,"abstract":"<div><h3>Background</h3><div>Sepsis is a leading cause of acute lung injury (ALI), with apoptosis of alveolar epithelial cells (AECs) playing a central role. Elevated lactate, a hallmark of sepsis-induced metabolic reprogramming, has recently been implicated in lysine lactylation. However, its contribution to AEC apoptosis and ALI pathogenesis remains unclear.</div></div><div><h3>Methods</h3><div>A cecal ligation and puncture (CLP) mouse model and LPS-stimulated AECs were used to investigate the role of lysine lactylation in AEC apoptosis. Histopathological analysis, western blotting, TdT-mediated dUTP-biotin nick end labeling (TUNEL) staining, chromatin immunoprecipitation (ChIP) assays, and pharmacological interventions with Oxamate, recombinant TNF-α, and the caspase-8 inhibitor Z-IETD-FMK were performed.</div></div><div><h3>Results</h3><div>Compared with sham controls, septic mice exhibited significantly elevated lactate levels, enhanced inflammation, increased pulmonary apoptosis, and aggravated lung injury. Both septic lung tissues and LPS-stimulated AECs showed significant upregulation of pan-lysine lactylation (pan-Kla) and histone H3 lysine 18 lactylation (H3K18la). ChIP analysis showed that H3K18la was highly enriched in the caspase-8 promoter region. Consistently, lactate exposure increased caspase-8 expression, which potentiated TNF-α-induced apoptosis in AECs. Pharmacological inhibition of lactate production or caspase-8 activity significantly alleviated pulmonary apoptosis and lung injury in septic mice.</div></div><div><h3>Conclusion</h3><div>Our results demonstrate that lactate-driven H3K18la promotes TNF-α-induced AEC apoptosis by upregulating caspase-8 in sepsis-induced ALI. Targeting this lactate/H3K18la/caspase-8 axis may represent a promising therapeutic strategy for sepsis-induced ALI.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114843"},"PeriodicalIF":3.5,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B","authors":"Taishi Josen ,&nbsp;Ryuzaburo Yuki ,&nbsp;Youhei Saito ,&nbsp;Takuya Honda ,&nbsp;Shuhei Soeda ,&nbsp;Yuji Nakayama","doi":"10.1016/j.yexcr.2025.114840","DOIUrl":"10.1016/j.yexcr.2025.114840","url":null,"abstract":"<div><div>Src signaling is aberrantly activated in various cancers, and therapeutic strategies targeting Src-dependent cancers have been developed. We previously reported that cells expressing the oncogenic mutant v-Src are resistant to microtubule-targeting agents (MTAs), yet paradoxically exhibiting sensitivity to the Aurora B inhibitor ZM-447439; however, the mechanism underlying this cytotoxicity remains unclear. In this study, we demonstrate that the Aurora B inhibitor ZM-447439 potentiates cell death in v-Src-expressing HeLa S3 and HCT116 cells, accompanied by the accumulation of tetraploid and polyploid cells. The pan-caspase inhibitor z-VAD-FMK treatment does not affect the cell death. Time-lapse imaging analysis reveals cell death with the feature of necrosis in ZM-447439-treated v-Src expressing cells: altered morphology and loss of membrane integrity without chromatin condensation. Although autophagic flux is impaired, the autophagosome accumulation does not contribute to cell death. Notably, the cathepsin B expression is elevated in v-Src-expressing cells, and the amount of mature active cathepsin B outside lysosomes is strongly increased upon ZM-447439 treatment in v-Src-expressing cells. Treatment with the cathepsin B inhibitor CA-074 methyl ester mitigates cell death, similar to the pan-cysteine cathepsin inhibitor E64d treatment. These results suggest that the Aurora B inhibitor ZM-447439 potentiates caspase-independent necrosis-like death in v-Src-expressing cells partly through the accumulation of extra-lysosomal cathepsin B. The Aurora B inhibitors might be promising therapeutic agents for Src-driven cancers.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114840"},"PeriodicalIF":3.5,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145631421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pseudane V alleviates ox-LDL-induced macrophage M1 polarization by inhibiting m6A modification of PPARGC1A","authors":"Tao Li ,&nbsp;Qi Pang ,&nbsp;Jun Pan ,&nbsp;Ya Gao ,&nbsp;Yuan Huang ,&nbsp;Wei Tian ,&nbsp;Junchuan Ran ,&nbsp;Zheng Zhu ,&nbsp;Yongbin Liu ,&nbsp;Kunsheng Li","doi":"10.1016/j.yexcr.2025.114842","DOIUrl":"10.1016/j.yexcr.2025.114842","url":null,"abstract":"<div><div>Atherosclerosis is driven by oxidized low-density lipoprotein (ox-LDL)-triggered macrophage malfunction, yet the precise pathways and effective counter-measures remain elusive. Here we delineated how N6-methyladenosine (m⁶A) RNA methylation governs ox-LDL-induced M1 macrophage polarization and evaluated marine natural products for therapeutic intervention. Human monocytic THP-1 cells differentiated into M0 macrophages were treated with ox-LDL. M1/M2 polarization states were analyzed using flow cytometry, and changes in polarization markers were examined using quantitative real-time polymerase chain reaction (qRT-PCR). Global m6A changes were detected using m⁶A dot blot and quantification analysis. Methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) were performed to identify downstream target genes of the ox-LDL-m⁶A pathway. The role of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) in ox-LDL-induced M1 polarization was analyzed. A high-throughput marine natural product library was employed to discover agents capable of reversing ox-LDL-driven macrophage polarization. ox-LDL induces macrophage M1 polarization, and M1 macrophages damage endothelial cells. ox-LDL-induced polarization of macrophages into the M1 phenotype was associated with increased global RNA m⁶A modification. High levels of m⁶A modification induced by ox-LDL suppressed PPARGC1A expression in a YTH domain family 2 (YTHDF2)-dependent manner, leading to M1 polarization. Pseudane V, a marine natural product, effectively reduced ox-LDL-induced M1 polarization and protected vascular endothelial cells by correcting abnormal m⁶A modification of PPARGC1A. In conclusion, ox-LDL induces m⁶A modification of PPARGC1A, suppressing its expression and promoting M1 polarization of macrophages, contributing to atherosclerosis development. Pseudane V counteracts excessive m⁶A modification caused by ox-LDL, preventing M1 polarization of macrophages. These findings suggest the potential use of Pseudane V in preventing atherosclerosis.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114842"},"PeriodicalIF":3.5,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145616577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sagittaria sagittifolia polysaccharide regulates Nrf2-mediated antioxidant to improve apoptosis and ferroptosis in high glucose-induced lens epithelial cells","authors":"Man-yu Zhou ,&nbsp;Yang Jiang ,&nbsp;Jia-zhen Ding ,&nbsp;Yao Liang ,&nbsp;Jian-bin Sun ,&nbsp;Bing-qing Liu ,&nbsp;Yan Liao","doi":"10.1016/j.yexcr.2025.114841","DOIUrl":"10.1016/j.yexcr.2025.114841","url":null,"abstract":"<div><div>Diabetic cataract (DC), a primary ocular complication of diabetes mellitus, remains a leading cause of global blindness. The bioactive polysaccharide <em>Sagittaria sagittifolia</em> polysaccharide (SSP) exhibits remarkable antioxidant and anti-apoptotic efficacy in age-related cataract models, yet its DC therapeutic potential is unexplored. This study investigated SSP's protective effects against high glucose (HG)-induced damage across three experimental models, focusing on nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant in apoptosis and ferroptosis regulation. In ex vivo rat lenses, SSP pretreatment (1 mg/mL, 24 h) significantly attenuated HG-induced (25 mM, 48 h) lens opacification. In human lens epithelial B3 (HLEB3) cells, SSP pretreatment (1 mg/mL, 24 h) markedly improved cell viability and proliferation under HG conditions (150 mM, 72 h). Mechanistically, SSP significantly decreased oxidative stress markers (malondialdehyde, protein carbonyls, reactive oxygen species) while restoring mitochondrial function and enhancing antioxidant capacity (glutathione levels, catalase activity). SSP activated the Nrf2 pathway, regulating key antioxidant proteins (NAD(P)H quinone dehydrogenase 1, heme oxygenase-1, thioredoxin (Trx), Trx2 and glutaredoxin 1 to mitigate HG-induced oxidative damage. SSP exerted anti-apoptotic effects by upregulating B-cell lymphoma-2 (Bcl-2) while suppressing Bcl-2-associated X and cleaved caspase-3 expression. SSP modulated ferroptosis by increasing Ferritin, system Xc⁻, and glutathione peroxidase 4 (GPX4) while reducing Fe²⁺ and acyl-CoA synthetase long-chain family member 4 (ACSL4) levels. In STZ-induced diabetic mice, SSP treatment ameliorated lens epithelial cells (LECs) morphological damage and reduced protein expression of caspase-3 and ACSL4, whereas increased protein expression of GPX4 and ferritin. Crucially, upon Nrf2 knockdown in HLEB3 cells via short interfering RNA, SSP confirmed its protective role by activating Nrf2 to inhibite apoptosis and ferroptosis. Collectively, these findings demonstrate that SSP protects LECs against HG-induced damage through Nrf2-mediated coordination of antioxidant defense, anti-apoptotic, and anti-ferroptotic mechanisms, highlighting its therapeutic potential for DC.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114841"},"PeriodicalIF":3.5,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145616578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Glycolysis inhibition and AMPK activation: a critical role of CTRP1 deficiency in the treatment of hypoxia-induced pulmonary hypertension","authors":"Yu Zhang ,&nbsp;Weiqiang Chen ,&nbsp;Kai Yang,&nbsp;Tao Hao,&nbsp;Wenfeng Cao,&nbsp;Shuqiang Dong","doi":"10.1016/j.yexcr.2025.114838","DOIUrl":"10.1016/j.yexcr.2025.114838","url":null,"abstract":"<div><div>In pulmonary hypertension (PH), metabolic enhancement of glycolysis drives a hyperproliferative and apoptosis-resistant phenotype in pulmonary artery smooth muscle cells (PASMCs), which is a key pathological process leading to pulmonary vascular remodeling. We aimed to uncover the role of CTRP1, a gene responsible for regulating glycolysis, in the modulation of PH-related pathogenesis. In the PH mouse and cell models established by hypoxia stimulation, the regulatory mechanism of CTRP1 deletion on the pathological characteristics of PH was explored. CTRP1 levels were significantly upregulated in PH mice, accompanied by an abnormal increase in lactate production and glycolysis-related key protein expressions (HK2 and PDHK1). Inhibition of CTRP1 markedly improved pulmonary artery pressure and right ventricular function in PH mice by reducing glycolysis levels. In vitro experiments further observed that CTRP1 knockdown suppressed the hypoxia-induced hyperproliferation and anti-apoptosis phenotype of PASMCs, with inhibition of glycolysis. Mechanically, downregulated CTRP1 resulted in p-AMPK activation and p-AKT/mTOR inhibition. This beneficial effect was reversed by AMPKα2 deficiency. Overall, CTRP1 deficiency reverses the hypoxia-induced hyperproliferation and antiapoptotic capacity of PASMCs by weakening glycolysis. These results provide evidence for CTRP1 as a potential therapeutic target in PH.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114838"},"PeriodicalIF":3.5,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fbxo45 promotes cell viability, invasion and sunitinib resistance of clear cell renal cell carcinoma by targeting Erbin","authors":"Xueshan Pan ,&nbsp;Ke Yu ,&nbsp;Kai Chen ,&nbsp;Jiao Wang ,&nbsp;Zheng Huang ,&nbsp;Jiewen Wang ,&nbsp;Tong Cao ,&nbsp;Jia Ma","doi":"10.1016/j.yexcr.2025.114839","DOIUrl":"10.1016/j.yexcr.2025.114839","url":null,"abstract":"<div><div>The mechanisms underlying the development and progression of clear cell renal cell carcinoma (ccRCC) and its sunitinib resistance are elusive. Fbxo45 is a member of the F-box protein family that has been demonstrated to participate in tumorigenesis. However, the role of Fbxo45 in ccRCC progression has not been characterized. This study aims to investigate the biological functions and molecular mechanism of Fbxo45 in ccRCC progression. We found that Fbxo45 knockdown inhibited the viability and motility of ccRCC cells, while Fbxo45 overexpression resulted in the opposite phenotype. Ectopic expression of Fbxo45 promoted tumor growth in mice. Fbxo45 expression was negatively correlated with Erbin expression, which has been reported to mediate anti-tumor activities in ccRCC. Furthermore, Fbxo45 facilitated ccRCC cell viability and motility by inhibiting Erbin. Notably, Fbxo45 upregulation reduced sunitinib sensitivity in ccRCC cells. Our results suggest that Fbxo45 could be a potential target for ccRCC treatment and sunitinib resistance.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114839"},"PeriodicalIF":3.5,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Elucidating the impact of trans-ned-19 on two-Pore channel 2 mutants of Dictyostelium: changes in intracellular calcium levels and subsequent effect on autophagic flux","authors":"Ashima Thakur,&nbsp;Shweta Saran","doi":"10.1016/j.yexcr.2025.114829","DOIUrl":"10.1016/j.yexcr.2025.114829","url":null,"abstract":"<div><div>Two-Pore Channel 2 (TPC2) are calcium (Ca²⁺) release channels regulated by Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP), primarily localized to the endolysosomal system. TPC2 regulates diverse Ca²⁺-dependent processes such as cell proliferation, development, migration, and autophagy. In the protist <em>Dictyostelium discoideum</em>, intracellular Ca²⁺ levels and autophagy are key determinants of cell-fate, particularly for stalk cell differentiation. To investigate the involvement of <em>Dd</em>TPC2 in NAADP-mediated Ca²⁺ signalling, we treated wild-type (Ax2) and various <em>tpc2</em> mutant strains, like overexpressors (<em>tpc2</em>^<em>OE</em>), knockout (<em>tpc2</em>^-), and rescue (<em>tpc2</em>^<em>Res</em>), with both NAADP-AM (NAADP agonist) and trans-Ned-19 (NAADP antagonist). Our findings show that trans-Ned-19 does not specifically inhibit <em>Dd</em>TPC2 activity during the proliferative (vegetative) stage, but acts as a specific TPC2 inhibitor in freshly starved cells or during multicellular development, as the phenotypes displayed by trans-Ned-19 treated Ax2 cells were similar to <em>tpc2</em>^<em>-</em> cells. Trans-Ned-19 colocalizes with lysosomes, consistent with the subcellular distribution of TPC2. Fluid-phase endocytosis was reduced in <em>tpc2</em>^- cells, implicating TPC2 in endolysosomal function. Intracellular calcium measurements demonstrated that NAADP regulates Ca²⁺ signalling through TPC2, as both NAADP-AM and trans-Ned-19 significantly modulated intracellular free Ca²⁺ levels in TPC2-expressing strains. Notably, trans-Ned-19 treatment reduced autophagic flux in Ax2 cells to <em>tpc2</em>^<em>-</em> levels, demonstrating a positive correlation between TPC2 and autophagic flux, further supported by rapamycin and 3-methyladenine treatment results. This study highlights TPC2 as a pivotal regulator of NAADP-mediated Ca²⁺ signalling and autophagy in <em>Dictyostelium</em>, with broad implications for understanding these processes in higher eukaryotes.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114829"},"PeriodicalIF":3.5,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145581909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metformin inhibits heterotopic ossification of mouse Achilles tendon by inhibiting the Nr4a1/Wnt/β-catenin signaling pathway","authors":"Danxia Zheng ,&nbsp;Mengyu Jiang ,&nbsp;Wenjie Wang ,&nbsp;Jianglin Yu ,&nbsp;Xiaoyang Qi ,&nbsp;Yixin Chen","doi":"10.1016/j.yexcr.2025.114824","DOIUrl":"10.1016/j.yexcr.2025.114824","url":null,"abstract":"<div><div>Heterotopic ossification is a pathological process characterized by aberrant bone formation in soft tissues, leading to joint pain, stiffness, functional impairment, and poor quality of life. We used a mouse Achilles tendon heterotopic ossification model and in vitro tendon-derived stem cells (TDSCs) assays to identify the molecular mechanism of metformin in prevention of heterotopic ossification. Metformin significantly attenuated heterotopic ossification, reducing ectopic bone volume and osteogenic gene expression. In vitro, metformin inhibited TDSCs osteogenic differentiation in a dose-dependent manner, decreasing calcium nodule deposition and osteogenic marker expression. Transcriptomic analysis revealed downregulated Nr4a1 expression in metformin-treated heterotopic ossification samples; in vitro experiments confirmed that Nr4a1 activation enhances TDSCs osteogenesis, and Nr4a1 knockdown suppresses osteogenesis. Metformin also reduced Wnt4 and β-catenin expression, suggesting that Nr4a1 promotes heterotopic ossification by positively regulating Wnt/β-catenin signaling. In sum, metformin downregulates expression of Nr4a1 in TDSCs, which suppresses osteogenic differentiation by inhibiting Wnt/β-catenin signaling. As a mediator of TDSC osteogenic differentiation, Nr4a1 may be a therapeutic target for heterotopic ossification.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114824"},"PeriodicalIF":3.5,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"lincRNA-p21 drives apoptosis and calcification of vascular smooth muscle cell via small extracellular vesicles under hyperphosphatemic conditions in chronic kidney disease","authors":"Jianbing Hao,&nbsp;Siyu Wang,&nbsp;Lirong Hao","doi":"10.1016/j.yexcr.2025.114779","DOIUrl":"10.1016/j.yexcr.2025.114779","url":null,"abstract":"<div><div>Vascular calcification, a major contributor to cardiovascular morbidity, involves pathological osteogenic transdifferentiation of vascular smooth muscle cell (VSMC) under hyperphosphatemic conditions in chronic kidney disease. This study investigates the role of lincRNA-p21 and small extracellular vesicles in phosphate-induced mouse aortic smooth muscle cell (MASMC) calcification. Exposure to phosphate (2.6 mmol/L) triggered time-dependent calcification, characterized by enhanced calcium deposition, endoplasmic reticulum remodeling, and intracellular calcium accumulation (p &lt; 0.05 vs. 24/48-h controls). Concurrently, the expression of osteogenic markers (BGP, OCN, and OPN) and lincRNA-p21 was significantly upregulated, whereas the expression of contractile phenotype-specific markers (SM22α, SM-MHC, and SM α-actin) was markedly down-regulated. This pattern of gene expression was correlated with MASMC osteogenic transdifferentiation. Small extracellular vesicles isolated from phosphate-treated MASMC exhibited elevated lincRNA-p21 levels (p &lt; 0.05) and induced calcification and apoptosis in recipient cells, suggesting small extracellular vesicles-mediated propagation of calcific signals. Functional studies demonstrated that lincRNA-p21 overexpression exacerbated calcification, apoptosis, and osteogenic marker expression, while its knockdown attenuated these effects (p &lt; 0.05). Time-course analyses revealed lincRNA-p21 dynamically regulates small extracellular vesicles secretion, calcium accumulation, and apoptotic pathways, acting as a molecular switch driving phosphate-induced calcification. These findings establish lincRNA-p21 as a critical mediator of MASMC calcification via small extracellular vesicles-dependent mechanisms, offering insights into therapeutic strategies for vascular calcification.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 2","pages":"Article 114779"},"PeriodicalIF":3.5,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145530515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ANXA1 inhibits ferroptosis in HUVECs via negative regulation of ferritinophagy","authors":"Jingjing Wang ,&nbsp;Jinqiu Jia ,&nbsp;Zitong Cao ,&nbsp;Zeming Cai ,&nbsp;Kai Zhang ,&nbsp;Jin He ,&nbsp;Chunyan Wu ,&nbsp;Zuo Wang","doi":"10.1016/j.yexcr.2025.114825","DOIUrl":"10.1016/j.yexcr.2025.114825","url":null,"abstract":"<div><div>Ferroptosis is a phospholipid peroxidation-mediated and iron-dependent cell death form. Inhibiting ferroptosis is a promising strategy for the prevention and treatment of cardiovascular diseases. Annexin A1 (ANXA1) is an endogenous anti-inflammatory mediator that plays an important regulatory role in cardiovascular diseases such as atherosclerosis, especially in inflammation suppression, protecting the heart from injury, and regulating vascular function. Ac2-26 is a synthetic peptide derived from the N-terminal 26 amino acids of ANXA1, which retains its anti-inflammatory properties. However, the regulatory mechanism of ANXA1 in atherosclerosis (AS) is not yet fully understood. This study aims to explore the specific role of ferroptosis in HUVECs and demonstrate that ANXA1 can disrupt ferritinophagy and protect endothelial function. Treatment with Ac2-26 or ANXA1-overexpressing HUVECs alleviated RSL3-induced endothelial cell dysfunction and inhibited lipid peroxidation, as evidenced by a reduction in ferrous ion levels and upregulation of GPX4, FTH1, and SLC7A11 protein expression, along with a downregulation of LC3-II and NCOA4 expression. In contrast, knockdown of ANXA1 in HUVECs failed to suppress the outcome of ferroptosis. Furthermore, co-immunoprecipitation analysis revealed that ANXA1 overexpression prevented ferritin degradation by disrupting the NCOA4-FTH1 protein-protein interaction, reducing the bioavailability of intracellular ferrous ions, thereby blocking ferroptosis. In conclusion, our findings identify a novel mechanism, showing that ANXA1 can inhibit ferroptosis via ferritinophagy, thereby alleviating endothelial dysfunction, which may provide a new therapeutic avenue for AS.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"454 1","pages":"Article 114825"},"PeriodicalIF":3.5,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145530576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}